Identification and characterization of an SKN7 homologue in Cryptococcus neoformans

F L Wormley1, G Heinrich, J L Miller

  • 1Department of Medicine/Division of Infectious Diseases, Duke University Medical Center, Duke South, Stead Bldg., Box 3353, Durham, NC 27710, USA. floyd.wormley@duke.edu

Insights

The SKN7 gene in Cryptococcus neoformans is important for resisting oxidative stress and contributes to virulence, though it is not essential for pathogenicity. SkN7 mutants also exhibit a novel flocculation behavior.

Area of Science:

  • Mycology
  • Molecular Biology
  • Pathogenesis

Background:

  • Cryptococcus neoformans causes life-threatening meningoencephalitis in immunocompromised individuals.
  • Understanding host defense evasion and virulence factors is crucial for C. neoformans.
  • Oxidative stress response genes are key targets for studying fungal resistance.

Purpose of the Study:

  • To identify and characterize the C. neoformans homologue of the Saccharomyces cerevisiae SKN7 gene.
  • To investigate the role of SKN7 in C. neoformans oxidative stress response and virulence.
  • To explore novel functions associated with SKN7 in C. neoformans.

Main Methods:

  • Targeted gene disruption was used to create skn7 mutants.
  • In vitro susceptibility to reactive oxygen species was assessed.
  • Virulence was evaluated using a mouse inhalational model.
  • Thioredoxin reductase expression was monitored under oxidative stress.

Main Results:

  • skn7 mutants showed increased susceptibility to reactive oxygen species in vitro.
  • skn7 mutants exhibited significantly reduced virulence in the mouse model.
  • Skn7 protein is essential for thioredoxin reductase expression during oxidative challenge.
  • skn7 mutants displayed a novel in vitro flocculation phenotype.

Conclusions:

  • SKN7 contributes to the overall virulence of C. neoformans but is not strictly required for pathogenicity.
  • The observed flocculation in skn7 mutants suggests a unique, previously uncharacterized function of SKN7.
  • Further research into SKN7's role in C. neoformans may reveal novel therapeutic targets.